Quest Diagnostics Inc vs Krispy Kreme Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Krispy Kreme Inc trades at $3.13 (market cap $537.85M). The key difference: Quest Diagnostics Inc is far larger — about 48.7× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays the higher dividend (3.47%). Which is the better fit depends on your goals.
| DGX | DNUT | |
|---|---|---|
Market Cap | $26.21B | $537.85M |
Sector | Health | Consumer Staples |
52-Week High | $238.50 | $4.70 |
52-Week Low | $173.49 | $2.92 |
Enterprise Value | $31.97B | $1.78B |
Dividend Yield | 1.45% | 3.47% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →